Monoclonal Clinical Trials in Guangzhou, Guangdong
3 recruitingGuangzhou, Guangdong, China
Showing 1–3 of 3 trials
Recruiting
Phase 2
Nodal-Region Sparing Short-Course RT With Chemo-PD-1/Bevacizumab vs. Short-Course RT With Chemotherapy as TNT in pMMR/MSS Locally Advanced Rectal Cancer
Short-course Radiotherapy Plus ChemotherapyNodal-Region Sparing Short-Course Radiotherapy Followed by Sequential Chemotherapy With PD-1 Monoclonal Antibody and Bevacizumab
Dechang Diao76 enrolled1 locationNCT07674732
Recruiting
Screening and Therapeutic Monitoring of Multiple Myeloma by MALDI-TOF MS Analysis
Multiple MyelomaM-ProteinMonoclonal Gammopathies
Zhujiang Hospital200 enrolled1 locationNCT05686447
Recruiting
Phase 2
Daratumumab, Bortezomib, Cyclophosphamide, and Dexamethasone Therapy for Patients with MIDD
Monoclonal Gammopathy of Renal Significance
Peking University People's Hospital20 enrolled3 locationsNCT06418477